Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Feb 11, 2022 SC 13G/A

An amendment to the SC 13G filing

View HTML
0000093751-22-000195.pdf
0000093751-22-000195.rtf
Feb 10, 2022 SC 13G/A

An amendment to the SC 13G filing

View HTML
0001104659-22-017828.pdf
0001104659-22-017828.rtf
Feb 09, 2022 SC 13G/A

An amendment to the SC 13G filing

View HTML
0000315066-22-001014.pdf
0000315066-22-001014.rtf
Feb 09, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-017068.pdf
0001104659-22-017068.rtf
0001104659-22-017068.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 07, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-012766.pdf
0001104659-22-012766.rtf
0001104659-22-012766.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 07, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-012826.pdf
0001104659-22-012826.rtf
0001104659-22-012826.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 03, 2022 SC 13G/A

An amendment to the SC 13G filing

View HTML
0000834237-22-005430.pdf
0000834237-22-005430.rtf
Feb 03, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-22-011363.pdf
0001104659-22-011363.rtf
0001104659-22-011363.xls
Feb 02, 2022 SC 13G/A

An amendment to the SC 13G filing

View HTML
0001445546-22-000736.pdf
0001445546-22-000736.rtf
Jan 31, 2022 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-22-009517.pdf
0001104659-22-009517.rtf
0001104659-22-009517.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
305 Madison Avenue|Morristown, NJ 07960|T: 844-782-ICPT
© 2022 Intercept Pharmaceuticals, Inc.